The management of diabetic foot ulcers (DFU) remains a challenge, and there is continuing uncertainty concerning optimal approaches to wound healing. The International Working Group of the Diabetic Foot (IWGDF) working group on wound healing has previously published systematic reviews of the evidence in 2008, 2012 and 2016 to inform protocols for routine care and to highlight areas which should be considered for further study. The working group has now updated this review by considering papers on the interventions to improve the healing of DFU's published between June 2014 and August 2018. Methodological quality of selected studies was independently assessed by a minimum of two reviewers using the recently published 21-point questionnaire as recommended by IWGDF/European Wound Management Association, as well as the previously incorporated Scottish Intercollegiate Guidelines Network criteria. Of the 2275 papers identified, 97 were finally selected for grading following full text review. Overall, there has been an improvement in study design and a significant rise in the number of published studies. While previous systematic reviews did not find any evidence to justify the use of newer therapies, except for negative pressure wound therapy in post-surgical wounds, in this review we found additional evidence to support some interventions including a sucrose-octasulfate dressing, the combined leucocyte, fibrin and platelet patch as well as topical application of some placental membrane products, all when used in addition to usual best care. Nonetheless, the assessment and comparison of published trials remains difficult with marked clinical heterogeneity between studies: in patient selection, study duration, standard of usual care provision and the timing and description of the clinical endpoints.

Download full-text PDF

Source
http://dx.doi.org/10.1002/dmrr.3284DOI Listing

Publication Analysis

Top Keywords

working group
12
foot ulcers
8
diabetic foot
8
wound healing
8
systematic reviews
8
published
5
effectiveness interventions
4
interventions enhance
4
healing
4
enhance healing
4

Similar Publications

Article Synopsis
  • Around 90% of varicella (chickenpox) infections are mild, but adults can experience more severe cases, prompting a study in Florence, Italy, to assess immunity levels post-vaccination.
  • A survey of 430 adults (ages 18-94) showed that 89.5% tested positive for varicella antibodies, with no significant differences based on sex or nationality.
  • The findings indicated that while vaccination efforts have improved immunity, there is still a notable susceptibility (11.6%) among women aged 18-49, emphasizing the need for ongoing vaccination campaigns and awareness.
View Article and Find Full Text PDF

Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.

Haematologica

August 2024

Antonino Trizzino, Simona Gobbi, Fraia Melchionda, Marco Zecca, Elena Mastrodicasa, Massimo Provenzi, Monica Cellini, Daniela Onofrillo, Marco Rabusin, Bernd Raffeiner, Rosamaria Mura, Vito Miraglia, Alessandra Tozzo.

Primary hemophagocytic lymphohistiocytosis (pHLH) is a severe, life-threatening hyperinflammatory syndrome caused by defects in genes of the granule-dependent cytotoxic pathway. Here we investigated the clinical presentation and outcome in a large cohort of 143 patients with pHLH diagnosed in the last 15 years and enrolled in the Italian registry. The median age at diagnosis was 12 months (interquartile range, 2-81), and 92 patients (64%) fulfilled the HLH-2004 criteria.

View Article and Find Full Text PDF
Article Synopsis
  • Major serotypes of Shiga toxin-producing E. coli (STEC) usually have a specific genetic region called the locus of enterocyte effacement (LEE) which helps them cause infections by forming lesions on intestinal cells.* -
  • There is limited information on STEC that lack this LEE, even though they can still be very harmful.* -
  • This study reports the complete genomes of eight LEE-negative STEC isolates found in patients with hemolytic-uremic syndrome, contributing valuable data to the understanding of these bacteria.*
View Article and Find Full Text PDF

A European code of good practice for hyperbaric oxygen therapy - Review 2022.

Diving Hyperb Med

December 2023

Prepared by the Working Group «SAFETY» of the COST Action B14 «HYPERBARIC OXYGEN THERAPY» May 2004 - Update 2022.

View Article and Find Full Text PDF

We studied the risk factors, etiology, clinical manifestations, and treatment outcomes of COVID-19-associated invasive candidiasis (COVID-IC) in adult patients admitted to six medical facilities in St. Petersburg. (November 2020-December 2022).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!